Why does PCOS cause acne, and what helps?
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Short answer
PCOS acne is driven by androgens acting on the oil glands, which enlarges them and thickens sebum, so lesions cluster on the jawline, chin and neck. Hormonal treatment is what changes it: the combined oral contraceptive pill and spironolactone both carry conditional recommendations in the 2024 American Academy of Dermatology acne guideline, alongside standard topical therapy.
Acne in PCOS is hormonal acne. Androgens bind receptors in the sebaceous gland, the gland enlarges, sebum production rises and its composition changes, and the follicle becomes blocked and inflamed. That is why PCOS acne concentrates along the lower face, jawline and neck, why it tends to be deep and tender rather than superficial, and why topical treatment alone often plateaus. Treating the androgen side is what shifts it.
Hormonal treatments that work
The 2024 American Academy of Dermatology acne guideline gives conditional recommendations for combined oral contraceptives and for spironolactone to address hormonal causes of acne, and a conditional recommendation for clascoterone, a topical androgen receptor blocker. Combined oral contraceptives lower ovarian androgen output and raise sex hormone binding globulin. Spironolactone blocks the androgen receptor at the sebaceous gland. Both take about three months before a fair judgement can be made.
What stays in the plan alongside
Hormonal treatment does not replace standard acne care. A topical retinoid plus benzoyl peroxide remains the backbone for most people, and oral antibiotics have a role in inflammatory acne but should be time limited rather than run for years. For severe acne, or acne that has failed standard oral and topical therapy, the AAD gives isotretinoin a strong recommendation. Scarring acne is a reason to escalate sooner rather than to wait out another six month trial.
Spironolactone requires contraception
Spironolactone is an anti-androgen and it carries the same reproductive caution in acne as in hirsutism. The FDA label states the drug "may affect sex differentiation of the male during embryogenesis" and advises avoiding it in pregnancy. The 2023 PCOS guideline requires that anti-androgens be used in combination with effective contraception, with explicit counselling about undervirilisation of a male fetus. In practice the pill and spironolactone are often used together, which covers both the acne and the contraception.
| Treatment | Target | Time to judge |
|---|---|---|
| Topical retinoid plus benzoyl peroxide | Follicular plugging, bacteria | 8 to 12 weeks |
| Combined oral contraceptive pill | Ovarian androgen production | 3 months |
| Spironolactone | Androgen receptor in the skin | 3 months |
| Clascoterone cream | Androgen receptor, topically | 12 weeks |
| Isotretinoin | Sebaceous gland size and output | Course of months |
If you have PCOS and jawline acne, ask for the hormonal options to be discussed at the same visit as the topicals, rather than after a year of antibiotics. If lesions are leaving marks or scars, say so explicitly, because that changes how quickly treatment should escalate.
The clinical detail
Androgen testing is not required to treat acne, and the Endocrine Society hirsutism guideline suggests against testing androgens in eumenorrhoeic women with only local unwanted hair growth. Where acne appears with irregular cycles or hirsutism, total and free testosterone by LC-MS/MS and an early morning follicular phase 17-hydroxyprogesterone are reasonable, measured off any combined oral contraceptive.
Spironolactone for acne is typically 50 to 100 mg daily, titrated to effect, and is used off-label; it is not FDA approved for acne. Routine potassium monitoring in healthy young women is low yield, with hyperkalaemia in 0.72 per cent of 974 women studied against a 0.76 per cent population rate. Isotretinoin requires pregnancy prevention under the iPLEDGE programme in the United States, with two forms of contraception and monthly testing.
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Sources
- Updated guidelines for the management of acne vulgaris, 2024. American Academy of Dermatology
- International Evidence-based Guideline for the Assessment and Management of PCOS, 2023 summary. Monash University Centre for Health Research and Implementation
- ALDACTONE (spironolactone) prescribing information. US Food and Drug Administration
- Acne. MedlinePlus, National Library of Medicine
This library is educational and is not individual medical advice. Read our Editorial and Medical Review Policy.